|
Dear bjj,
My doctor told me the same thing, that my risk outweighed my benifit from receiving, Herceptin. My pathology is as follows: stage 1, 1.3cm tumor, node negative, vacular lymphatic invsion, negative, er/pr+, grade 3, Her2+++. I had several discussions with him, where he would break down the % of recurrence, and the therapies I was receiving. At the end of the day, I had about a 4% risk of recurrence without the Herceptin. I couldn't stop thinking about whether or not I was making the right decision. I decided to get 2nd and 3rd opinions, so I went before a local tumor board (different hospital from treatment) and down to Stanford University. I saw 4 oncs and 3 told me I would benefit from Herceptin. The onc down at stanford, kind of painted a different picture as far as recurrence (a littel highter with Her2+++). I went back to my onc and before I could tell him how I was feeling, he said, I should do Herceptin. I think I would have changed oncs to get the Herceptin.
I hope this helps you with your decision.
Karen
|